82 results
Page 2 of 5
8-K
EX-99.1
0z22mn5u
8 Aug 23
Arvinas Reports Second Quarter 2023 Financial Results and Provides Corporate Update
7:03am
8-K
EX-3.1
b8wo2sor mzfnf8dd
21 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:32pm
8-K
EX-99.1
f34daz7686r
8 Jun 23
Regulation FD Disclosure
7:14am
8-K
EX-99.2
967liyw5fom2
8 Jun 23
Regulation FD Disclosure
7:14am
8-K
3arje
8 Jun 23
Regulation FD Disclosure
7:14am
8-K
EX-99.1
ss8gye8vcme q77
22 Nov 22
Regulation FD Disclosure
7:31am
8-K
EX-99.1
n7mww2if
17 Feb 22
Regulation FD Disclosure
8:01am
8-K
EX-99.2
d6rhe f1b
17 Feb 22
Regulation FD Disclosure
8:01am
8-K
9unzk
17 Feb 22
Regulation FD Disclosure
8:01am
8-K
EX-99.2
kn6is9
10 Dec 21
Regulation FD Disclosure
8:16am
424B5
gcvefed
6 Aug 21
Prospectus supplement for primary offering
4:34pm
8-K
EX-10.2
k0di3c33xuwe2nhk 1c
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTACĀ® Protein
7:30am
8-K
EX-10.3
l7a3 nyjsbpvem
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTACĀ® Protein
7:30am
424B5
wkx9 fnoyp4
16 Dec 20
Prospectus supplement for primary offering
4:01pm
424B5
fl0lh
14 Dec 20
Prospectus supplement for primary offering
4:48pm